Global Live Attenuated Vaccine for Pig Market Growth 2026-2032
The global Live Attenuated Vaccine for Pig market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Live Attenuated Vaccine for Pig is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by 'killing' the virus.
United States market for Live Attenuated Vaccine for Pig is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Attenuated Vaccine for Pig is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Attenuated Vaccine for Pig is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Attenuated Vaccine for Pig players cover Merck, Pfizer, GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Live Attenuated Vaccine for Pig Industry Forecast? looks at past sales and reviews total world Live Attenuated Vaccine for Pig sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Attenuated Vaccine for Pig sales for 2026 through 2032. With Live Attenuated Vaccine for Pig sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Vaccine for Pig industry.
This Insight Report provides a comprehensive analysis of the global Live Attenuated Vaccine for Pig landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Vaccine for Pig portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Attenuated Vaccine for Pig market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Vaccine for Pig and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Vaccine for Pig.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Vaccine for Pig market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Live Attenuated Vaccine for Pig is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by 'killing' the virus.
United States market for Live Attenuated Vaccine for Pig is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Attenuated Vaccine for Pig is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Attenuated Vaccine for Pig is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Attenuated Vaccine for Pig players cover Merck, Pfizer, GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Live Attenuated Vaccine for Pig Industry Forecast? looks at past sales and reviews total world Live Attenuated Vaccine for Pig sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Attenuated Vaccine for Pig sales for 2026 through 2032. With Live Attenuated Vaccine for Pig sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Vaccine for Pig industry.
This Insight Report provides a comprehensive analysis of the global Live Attenuated Vaccine for Pig landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Vaccine for Pig portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Attenuated Vaccine for Pig market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Vaccine for Pig and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Vaccine for Pig.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Vaccine for Pig market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Bacterial Vaccines
- Viral Vaccines
- Piglet
- Adult Pig
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Pfizer
- GlaxoSmithKline
- Astellas Pharma
- Johnson & Johnson
- CSL
- KM Biologics
- MSD Animal Health
- What is the 10-year outlook for the global Live Attenuated Vaccine for Pig market?
- What factors are driving Live Attenuated Vaccine for Pig market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Live Attenuated Vaccine for Pig market opportunities vary by end market size?
- How does Live Attenuated Vaccine for Pig break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Attenuated Vaccine for Pig Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Attenuated Vaccine for Pig by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Attenuated Vaccine for Pig by Country/Region, 2021, 2025 & 2032
2.2 Live Attenuated Vaccine for Pig Segment by Type
2.2.1 Bacterial Vaccines
2.2.2 Viral Vaccines
2.2.3 Live Attenuated Vaccine for Pig Sales by Type
2.2.3.1 Global Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
2.2.3.2 Global Live Attenuated Vaccine for Pig Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Live Attenuated Vaccine for Pig Sale Price by Type (2021-2026)
2.3 Live Attenuated Vaccine for Pig Segment by Application
2.3.1 Piglet
2.3.2 Adult Pig
2.3.3 Live Attenuated Vaccine for Pig Sales by Application
2.3.3.1 Global Live Attenuated Vaccine for Pig Sale Market Share by Application (2021-2026)
2.3.3.2 Global Live Attenuated Vaccine for Pig Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Live Attenuated Vaccine for Pig Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Attenuated Vaccine for Pig Breakdown Data by Company
3.1.1 Global Live Attenuated Vaccine for Pig Annual Sales by Company (2021-2026)
3.1.2 Global Live Attenuated Vaccine for Pig Sales Market Share by Company (2021-2026)
3.2 Global Live Attenuated Vaccine for Pig Annual Revenue by Company (2021-2026)
3.2.1 Global Live Attenuated Vaccine for Pig Revenue by Company (2021-2026)
3.2.2 Global Live Attenuated Vaccine for Pig Revenue Market Share by Company (2021-2026)
3.3 Global Live Attenuated Vaccine for Pig Sale Price by Company
3.4 Key Manufacturers Live Attenuated Vaccine for Pig Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Vaccine for Pig Product Location Distribution
3.4.2 Players Live Attenuated Vaccine for Pig Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE ATTENUATED VACCINE FOR PIG BY GEOGRAPHIC REGION
4.1 World Historic Live Attenuated Vaccine for Pig Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Attenuated Vaccine for Pig Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Attenuated Vaccine for Pig Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Attenuated Vaccine for Pig Market Size by Country/Region (2021-2026)
4.2.1 Global Live Attenuated Vaccine for Pig Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Attenuated Vaccine for Pig Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Attenuated Vaccine for Pig Sales Growth
4.4 APAC Live Attenuated Vaccine for Pig Sales Growth
4.5 Europe Live Attenuated Vaccine for Pig Sales Growth
4.6 Middle East & Africa Live Attenuated Vaccine for Pig Sales Growth
5 AMERICAS
5.1 Americas Live Attenuated Vaccine for Pig Sales by Country
5.1.1 Americas Live Attenuated Vaccine for Pig Sales by Country (2021-2026)
5.1.2 Americas Live Attenuated Vaccine for Pig Revenue by Country (2021-2026)
5.2 Americas Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
5.3 Americas Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Vaccine for Pig Sales by Region
6.1.1 APAC Live Attenuated Vaccine for Pig Sales by Region (2021-2026)
6.1.2 APAC Live Attenuated Vaccine for Pig Revenue by Region (2021-2026)
6.2 APAC Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
6.3 APAC Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Attenuated Vaccine for Pig by Country
7.1.1 Europe Live Attenuated Vaccine for Pig Sales by Country (2021-2026)
7.1.2 Europe Live Attenuated Vaccine for Pig Revenue by Country (2021-2026)
7.2 Europe Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
7.3 Europe Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Attenuated Vaccine for Pig by Country
8.1.1 Middle East & Africa Live Attenuated Vaccine for Pig Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Attenuated Vaccine for Pig Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
8.3 Middle East & Africa Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Vaccine for Pig
10.3 Manufacturing Process Analysis of Live Attenuated Vaccine for Pig
10.4 Industry Chain Structure of Live Attenuated Vaccine for Pig
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Vaccine for Pig Distributors
11.3 Live Attenuated Vaccine for Pig Customer
12 WORLD FORECAST REVIEW FOR LIVE ATTENUATED VACCINE FOR PIG BY GEOGRAPHIC REGION
12.1 Global Live Attenuated Vaccine for Pig Market Size Forecast by Region
12.1.1 Global Live Attenuated Vaccine for Pig Forecast by Region (2027-2032)
12.1.2 Global Live Attenuated Vaccine for Pig Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Attenuated Vaccine for Pig Forecast by Type (2027-2032)
12.7 Global Live Attenuated Vaccine for Pig Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.1.3 Merck Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.2.3 Pfizer Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Information
13.4.2 Astellas Pharma Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.4.3 Astellas Pharma Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Astellas Pharma Main Business Overview
13.4.5 Astellas Pharma Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.5.3 Johnson & Johnson Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.6.3 CSL Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.7.3 KM Biologics Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 MSD Animal Health
13.8.1 MSD Animal Health Company Information
13.8.2 MSD Animal Health Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.8.3 MSD Animal Health Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MSD Animal Health Main Business Overview
13.8.5 MSD Animal Health Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Attenuated Vaccine for Pig Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Attenuated Vaccine for Pig by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Attenuated Vaccine for Pig by Country/Region, 2021, 2025 & 2032
2.2 Live Attenuated Vaccine for Pig Segment by Type
2.2.1 Bacterial Vaccines
2.2.2 Viral Vaccines
2.2.3 Live Attenuated Vaccine for Pig Sales by Type
2.2.3.1 Global Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
2.2.3.2 Global Live Attenuated Vaccine for Pig Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Live Attenuated Vaccine for Pig Sale Price by Type (2021-2026)
2.3 Live Attenuated Vaccine for Pig Segment by Application
2.3.1 Piglet
2.3.2 Adult Pig
2.3.3 Live Attenuated Vaccine for Pig Sales by Application
2.3.3.1 Global Live Attenuated Vaccine for Pig Sale Market Share by Application (2021-2026)
2.3.3.2 Global Live Attenuated Vaccine for Pig Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Live Attenuated Vaccine for Pig Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Attenuated Vaccine for Pig Breakdown Data by Company
3.1.1 Global Live Attenuated Vaccine for Pig Annual Sales by Company (2021-2026)
3.1.2 Global Live Attenuated Vaccine for Pig Sales Market Share by Company (2021-2026)
3.2 Global Live Attenuated Vaccine for Pig Annual Revenue by Company (2021-2026)
3.2.1 Global Live Attenuated Vaccine for Pig Revenue by Company (2021-2026)
3.2.2 Global Live Attenuated Vaccine for Pig Revenue Market Share by Company (2021-2026)
3.3 Global Live Attenuated Vaccine for Pig Sale Price by Company
3.4 Key Manufacturers Live Attenuated Vaccine for Pig Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Vaccine for Pig Product Location Distribution
3.4.2 Players Live Attenuated Vaccine for Pig Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE ATTENUATED VACCINE FOR PIG BY GEOGRAPHIC REGION
4.1 World Historic Live Attenuated Vaccine for Pig Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Attenuated Vaccine for Pig Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Attenuated Vaccine for Pig Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Attenuated Vaccine for Pig Market Size by Country/Region (2021-2026)
4.2.1 Global Live Attenuated Vaccine for Pig Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Attenuated Vaccine for Pig Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Attenuated Vaccine for Pig Sales Growth
4.4 APAC Live Attenuated Vaccine for Pig Sales Growth
4.5 Europe Live Attenuated Vaccine for Pig Sales Growth
4.6 Middle East & Africa Live Attenuated Vaccine for Pig Sales Growth
5 AMERICAS
5.1 Americas Live Attenuated Vaccine for Pig Sales by Country
5.1.1 Americas Live Attenuated Vaccine for Pig Sales by Country (2021-2026)
5.1.2 Americas Live Attenuated Vaccine for Pig Revenue by Country (2021-2026)
5.2 Americas Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
5.3 Americas Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Vaccine for Pig Sales by Region
6.1.1 APAC Live Attenuated Vaccine for Pig Sales by Region (2021-2026)
6.1.2 APAC Live Attenuated Vaccine for Pig Revenue by Region (2021-2026)
6.2 APAC Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
6.3 APAC Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Attenuated Vaccine for Pig by Country
7.1.1 Europe Live Attenuated Vaccine for Pig Sales by Country (2021-2026)
7.1.2 Europe Live Attenuated Vaccine for Pig Revenue by Country (2021-2026)
7.2 Europe Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
7.3 Europe Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Attenuated Vaccine for Pig by Country
8.1.1 Middle East & Africa Live Attenuated Vaccine for Pig Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Attenuated Vaccine for Pig Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Attenuated Vaccine for Pig Sales by Type (2021-2026)
8.3 Middle East & Africa Live Attenuated Vaccine for Pig Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Vaccine for Pig
10.3 Manufacturing Process Analysis of Live Attenuated Vaccine for Pig
10.4 Industry Chain Structure of Live Attenuated Vaccine for Pig
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Vaccine for Pig Distributors
11.3 Live Attenuated Vaccine for Pig Customer
12 WORLD FORECAST REVIEW FOR LIVE ATTENUATED VACCINE FOR PIG BY GEOGRAPHIC REGION
12.1 Global Live Attenuated Vaccine for Pig Market Size Forecast by Region
12.1.1 Global Live Attenuated Vaccine for Pig Forecast by Region (2027-2032)
12.1.2 Global Live Attenuated Vaccine for Pig Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Attenuated Vaccine for Pig Forecast by Type (2027-2032)
12.7 Global Live Attenuated Vaccine for Pig Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.1.3 Merck Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.2.3 Pfizer Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Information
13.4.2 Astellas Pharma Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.4.3 Astellas Pharma Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Astellas Pharma Main Business Overview
13.4.5 Astellas Pharma Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.5.3 Johnson & Johnson Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.6.3 CSL Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.7.3 KM Biologics Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 MSD Animal Health
13.8.1 MSD Animal Health Company Information
13.8.2 MSD Animal Health Live Attenuated Vaccine for Pig Product Portfolios and Specifications
13.8.3 MSD Animal Health Live Attenuated Vaccine for Pig Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MSD Animal Health Main Business Overview
13.8.5 MSD Animal Health Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Live Attenuated Vaccine for Pig Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Attenuated Vaccine for Pig Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bacterial Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Global Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 6. Global Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Table 7. Global Live Attenuated Vaccine for Pig Revenue by Type (2021-2026) & ($ million)
Table 8. Global Live Attenuated Vaccine for Pig Revenue Market Share by Type (2021-2026)
Table 9. Global Live Attenuated Vaccine for Pig Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Live Attenuated Vaccine for Pig Sale by Application (2021-2026) & (Units)
Table 11. Global Live Attenuated Vaccine for Pig Sale Market Share by Application (2021-2026)
Table 12. Global Live Attenuated Vaccine for Pig Revenue by Application (2021-2026) & ($ million)
Table 13. Global Live Attenuated Vaccine for Pig Revenue Market Share by Application (2021-2026)
Table 14. Global Live Attenuated Vaccine for Pig Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Live Attenuated Vaccine for Pig Sales by Company (2021-2026) & (Units)
Table 16. Global Live Attenuated Vaccine for Pig Sales Market Share by Company (2021-2026)
Table 17. Global Live Attenuated Vaccine for Pig Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Live Attenuated Vaccine for Pig Revenue Market Share by Company (2021-2026)
Table 19. Global Live Attenuated Vaccine for Pig Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Live Attenuated Vaccine for Pig Producing Area Distribution and Sales Area
Table 21. Players Live Attenuated Vaccine for Pig Products Offered
Table 22. Live Attenuated Vaccine for Pig Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Live Attenuated Vaccine for Pig Sales by Geographic Region (2021-2026) & (Units)
Table 26. Global Live Attenuated Vaccine for Pig Sales Market Share Geographic Region (2021-2026)
Table 27. Global Live Attenuated Vaccine for Pig Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Live Attenuated Vaccine for Pig Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Live Attenuated Vaccine for Pig Sales by Country/Region (2021-2026) & (Units)
Table 30. Global Live Attenuated Vaccine for Pig Sales Market Share by Country/Region (2021-2026)
Table 31. Global Live Attenuated Vaccine for Pig Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Live Attenuated Vaccine for Pig Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Live Attenuated Vaccine for Pig Sales by Country (2021-2026) & (Units)
Table 34. Americas Live Attenuated Vaccine for Pig Sales Market Share by Country (2021-2026)
Table 35. Americas Live Attenuated Vaccine for Pig Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 37. Americas Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 38. APAC Live Attenuated Vaccine for Pig Sales by Region (2021-2026) & (Units)
Table 39. APAC Live Attenuated Vaccine for Pig Sales Market Share by Region (2021-2026)
Table 40. APAC Live Attenuated Vaccine for Pig Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 42. APAC Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 43. Europe Live Attenuated Vaccine for Pig Sales by Country (2021-2026) & (Units)
Table 44. Europe Live Attenuated Vaccine for Pig Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 46. Europe Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 47. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Country (2021-2026) & (Units)
Table 48. Middle East & Africa Live Attenuated Vaccine for Pig Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 50. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Live Attenuated Vaccine for Pig
Table 52. Key Market Challenges & Risks of Live Attenuated Vaccine for Pig
Table 53. Key Industry Trends of Live Attenuated Vaccine for Pig
Table 54. Live Attenuated Vaccine for Pig Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Live Attenuated Vaccine for Pig Distributors List
Table 57. Live Attenuated Vaccine for Pig Customer List
Table 58. Global Live Attenuated Vaccine for Pig Sales Forecast by Region (2027-2032) & (Units)
Table 59. Global Live Attenuated Vaccine for Pig Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Live Attenuated Vaccine for Pig Sales Forecast by Country (2027-2032) & (Units)
Table 61. Americas Live Attenuated Vaccine for Pig Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Live Attenuated Vaccine for Pig Sales Forecast by Region (2027-2032) & (Units)
Table 63. APAC Live Attenuated Vaccine for Pig Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Live Attenuated Vaccine for Pig Sales Forecast by Country (2027-2032) & (Units)
Table 65. Europe Live Attenuated Vaccine for Pig Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Live Attenuated Vaccine for Pig Sales Forecast by Country (2027-2032) & (Units)
Table 67. Middle East & Africa Live Attenuated Vaccine for Pig Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Live Attenuated Vaccine for Pig Sales Forecast by Type (2027-2032) & (Units)
Table 69. Global Live Attenuated Vaccine for Pig Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Live Attenuated Vaccine for Pig Sales Forecast by Application (2027-2032) & (Units)
Table 71. Global Live Attenuated Vaccine for Pig Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 74. Merck Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Pfizer Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 79. Pfizer Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. GlaxoSmithKline Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 84. GlaxoSmithKline Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GlaxoSmithKline Main Business
Table 86. GlaxoSmithKline Latest Developments
Table 87. Astellas Pharma Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 88. Astellas Pharma Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 89. Astellas Pharma Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Astellas Pharma Main Business
Table 91. Astellas Pharma Latest Developments
Table 92. Johnson & Johnson Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 94. Johnson & Johnson Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. CSL Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 99. CSL Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. CSL Main Business
Table 101. CSL Latest Developments
Table 102. KM Biologics Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 104. KM Biologics Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. MSD Animal Health Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 108. MSD Animal Health Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 109. MSD Animal Health Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. MSD Animal Health Main Business
Table 111. MSD Animal Health Latest Developments
Table 1. Live Attenuated Vaccine for Pig Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Attenuated Vaccine for Pig Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bacterial Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Global Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 6. Global Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Table 7. Global Live Attenuated Vaccine for Pig Revenue by Type (2021-2026) & ($ million)
Table 8. Global Live Attenuated Vaccine for Pig Revenue Market Share by Type (2021-2026)
Table 9. Global Live Attenuated Vaccine for Pig Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Live Attenuated Vaccine for Pig Sale by Application (2021-2026) & (Units)
Table 11. Global Live Attenuated Vaccine for Pig Sale Market Share by Application (2021-2026)
Table 12. Global Live Attenuated Vaccine for Pig Revenue by Application (2021-2026) & ($ million)
Table 13. Global Live Attenuated Vaccine for Pig Revenue Market Share by Application (2021-2026)
Table 14. Global Live Attenuated Vaccine for Pig Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Live Attenuated Vaccine for Pig Sales by Company (2021-2026) & (Units)
Table 16. Global Live Attenuated Vaccine for Pig Sales Market Share by Company (2021-2026)
Table 17. Global Live Attenuated Vaccine for Pig Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Live Attenuated Vaccine for Pig Revenue Market Share by Company (2021-2026)
Table 19. Global Live Attenuated Vaccine for Pig Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Live Attenuated Vaccine for Pig Producing Area Distribution and Sales Area
Table 21. Players Live Attenuated Vaccine for Pig Products Offered
Table 22. Live Attenuated Vaccine for Pig Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Live Attenuated Vaccine for Pig Sales by Geographic Region (2021-2026) & (Units)
Table 26. Global Live Attenuated Vaccine for Pig Sales Market Share Geographic Region (2021-2026)
Table 27. Global Live Attenuated Vaccine for Pig Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Live Attenuated Vaccine for Pig Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Live Attenuated Vaccine for Pig Sales by Country/Region (2021-2026) & (Units)
Table 30. Global Live Attenuated Vaccine for Pig Sales Market Share by Country/Region (2021-2026)
Table 31. Global Live Attenuated Vaccine for Pig Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Live Attenuated Vaccine for Pig Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Live Attenuated Vaccine for Pig Sales by Country (2021-2026) & (Units)
Table 34. Americas Live Attenuated Vaccine for Pig Sales Market Share by Country (2021-2026)
Table 35. Americas Live Attenuated Vaccine for Pig Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 37. Americas Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 38. APAC Live Attenuated Vaccine for Pig Sales by Region (2021-2026) & (Units)
Table 39. APAC Live Attenuated Vaccine for Pig Sales Market Share by Region (2021-2026)
Table 40. APAC Live Attenuated Vaccine for Pig Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 42. APAC Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 43. Europe Live Attenuated Vaccine for Pig Sales by Country (2021-2026) & (Units)
Table 44. Europe Live Attenuated Vaccine for Pig Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 46. Europe Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 47. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Country (2021-2026) & (Units)
Table 48. Middle East & Africa Live Attenuated Vaccine for Pig Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Type (2021-2026) & (Units)
Table 50. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Application (2021-2026) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Live Attenuated Vaccine for Pig
Table 52. Key Market Challenges & Risks of Live Attenuated Vaccine for Pig
Table 53. Key Industry Trends of Live Attenuated Vaccine for Pig
Table 54. Live Attenuated Vaccine for Pig Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Live Attenuated Vaccine for Pig Distributors List
Table 57. Live Attenuated Vaccine for Pig Customer List
Table 58. Global Live Attenuated Vaccine for Pig Sales Forecast by Region (2027-2032) & (Units)
Table 59. Global Live Attenuated Vaccine for Pig Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Live Attenuated Vaccine for Pig Sales Forecast by Country (2027-2032) & (Units)
Table 61. Americas Live Attenuated Vaccine for Pig Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Live Attenuated Vaccine for Pig Sales Forecast by Region (2027-2032) & (Units)
Table 63. APAC Live Attenuated Vaccine for Pig Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Live Attenuated Vaccine for Pig Sales Forecast by Country (2027-2032) & (Units)
Table 65. Europe Live Attenuated Vaccine for Pig Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Live Attenuated Vaccine for Pig Sales Forecast by Country (2027-2032) & (Units)
Table 67. Middle East & Africa Live Attenuated Vaccine for Pig Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Live Attenuated Vaccine for Pig Sales Forecast by Type (2027-2032) & (Units)
Table 69. Global Live Attenuated Vaccine for Pig Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Live Attenuated Vaccine for Pig Sales Forecast by Application (2027-2032) & (Units)
Table 71. Global Live Attenuated Vaccine for Pig Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 74. Merck Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Pfizer Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 79. Pfizer Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. GlaxoSmithKline Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 84. GlaxoSmithKline Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GlaxoSmithKline Main Business
Table 86. GlaxoSmithKline Latest Developments
Table 87. Astellas Pharma Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 88. Astellas Pharma Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 89. Astellas Pharma Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Astellas Pharma Main Business
Table 91. Astellas Pharma Latest Developments
Table 92. Johnson & Johnson Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 94. Johnson & Johnson Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. CSL Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 99. CSL Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. CSL Main Business
Table 101. CSL Latest Developments
Table 102. KM Biologics Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 104. KM Biologics Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. MSD Animal Health Basic Information, Live Attenuated Vaccine for Pig Manufacturing Base, Sales Area and Its Competitors
Table 108. MSD Animal Health Live Attenuated Vaccine for Pig Product Portfolios and Specifications
Table 109. MSD Animal Health Live Attenuated Vaccine for Pig Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. MSD Animal Health Main Business
Table 111. MSD Animal Health Latest Developments
LIST OF FIGURES
Figure 1. Picture of Live Attenuated Vaccine for Pig
Figure 2. Live Attenuated Vaccine for Pig Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Vaccine for Pig Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Live Attenuated Vaccine for Pig Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Attenuated Vaccine for Pig Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Attenuated Vaccine for Pig Sales Market Share by Country/Region (2025)
Figure 10. Live Attenuated Vaccine for Pig Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bacterial Vaccines
Figure 12. Product Picture of Viral Vaccines
Figure 13. Global Live Attenuated Vaccine for Pig Sales Market Share by Type in 2026
Figure 14. Global Live Attenuated Vaccine for Pig Revenue Market Share by Type (2021-2026)
Figure 15. Live Attenuated Vaccine for Pig Consumed in Piglet
Figure 16. Global Live Attenuated Vaccine for Pig Market: Piglet (2021-2026) & (Units)
Figure 17. Live Attenuated Vaccine for Pig Consumed in Adult Pig
Figure 18. Global Live Attenuated Vaccine for Pig Market: Adult Pig (2021-2026) & (Units)
Figure 19. Global Live Attenuated Vaccine for Pig Sale Market Share by Application (2025)
Figure 20. Global Live Attenuated Vaccine for Pig Revenue Market Share by Application in 2026
Figure 21. Live Attenuated Vaccine for Pig Sales by Company in 2026 (Units)
Figure 22. Global Live Attenuated Vaccine for Pig Sales Market Share by Company in 2026
Figure 23. Live Attenuated Vaccine for Pig Revenue by Company in 2026 ($ millions)
Figure 24. Global Live Attenuated Vaccine for Pig Revenue Market Share by Company in 2026
Figure 25. Global Live Attenuated Vaccine for Pig Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Live Attenuated Vaccine for Pig Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 28. Americas Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 29. APAC Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 30. APAC Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 31. Europe Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 32. Europe Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 34. Middle East & Africa Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 35. Americas Live Attenuated Vaccine for Pig Sales Market Share by Country in 2026
Figure 36. Americas Live Attenuated Vaccine for Pig Revenue Market Share by Country (2021-2026)
Figure 37. Americas Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 38. Americas Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 39. United States Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Live Attenuated Vaccine for Pig Sales Market Share by Region in 2026
Figure 44. APAC Live Attenuated Vaccine for Pig Revenue Market Share by Region (2021-2026)
Figure 45. APAC Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 46. APAC Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 47. China Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 51. India Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Live Attenuated Vaccine for Pig Sales Market Share by Country in 2026
Figure 55. Europe Live Attenuated Vaccine for Pig Revenue Market Share by Country (2021-2026)
Figure 56. Europe Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 57. Europe Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 58. Germany Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 59. France Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Live Attenuated Vaccine for Pig Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 66. Egypt Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Live Attenuated Vaccine for Pig in 2026
Figure 72. Manufacturing Process Analysis of Live Attenuated Vaccine for Pig
Figure 73. Industry Chain Structure of Live Attenuated Vaccine for Pig
Figure 74. Channels of Distribution
Figure 75. Global Live Attenuated Vaccine for Pig Sales Market Forecast by Region (2027-2032)
Figure 76. Global Live Attenuated Vaccine for Pig Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Live Attenuated Vaccine for Pig Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Live Attenuated Vaccine for Pig Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Live Attenuated Vaccine for Pig Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Live Attenuated Vaccine for Pig Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Live Attenuated Vaccine for Pig
Figure 2. Live Attenuated Vaccine for Pig Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Vaccine for Pig Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Live Attenuated Vaccine for Pig Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Attenuated Vaccine for Pig Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Attenuated Vaccine for Pig Sales Market Share by Country/Region (2025)
Figure 10. Live Attenuated Vaccine for Pig Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bacterial Vaccines
Figure 12. Product Picture of Viral Vaccines
Figure 13. Global Live Attenuated Vaccine for Pig Sales Market Share by Type in 2026
Figure 14. Global Live Attenuated Vaccine for Pig Revenue Market Share by Type (2021-2026)
Figure 15. Live Attenuated Vaccine for Pig Consumed in Piglet
Figure 16. Global Live Attenuated Vaccine for Pig Market: Piglet (2021-2026) & (Units)
Figure 17. Live Attenuated Vaccine for Pig Consumed in Adult Pig
Figure 18. Global Live Attenuated Vaccine for Pig Market: Adult Pig (2021-2026) & (Units)
Figure 19. Global Live Attenuated Vaccine for Pig Sale Market Share by Application (2025)
Figure 20. Global Live Attenuated Vaccine for Pig Revenue Market Share by Application in 2026
Figure 21. Live Attenuated Vaccine for Pig Sales by Company in 2026 (Units)
Figure 22. Global Live Attenuated Vaccine for Pig Sales Market Share by Company in 2026
Figure 23. Live Attenuated Vaccine for Pig Revenue by Company in 2026 ($ millions)
Figure 24. Global Live Attenuated Vaccine for Pig Revenue Market Share by Company in 2026
Figure 25. Global Live Attenuated Vaccine for Pig Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Live Attenuated Vaccine for Pig Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 28. Americas Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 29. APAC Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 30. APAC Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 31. Europe Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 32. Europe Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Live Attenuated Vaccine for Pig Sales 2021-2026 (Units)
Figure 34. Middle East & Africa Live Attenuated Vaccine for Pig Revenue 2021-2026 ($ millions)
Figure 35. Americas Live Attenuated Vaccine for Pig Sales Market Share by Country in 2026
Figure 36. Americas Live Attenuated Vaccine for Pig Revenue Market Share by Country (2021-2026)
Figure 37. Americas Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 38. Americas Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 39. United States Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Live Attenuated Vaccine for Pig Sales Market Share by Region in 2026
Figure 44. APAC Live Attenuated Vaccine for Pig Revenue Market Share by Region (2021-2026)
Figure 45. APAC Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 46. APAC Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 47. China Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 51. India Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Live Attenuated Vaccine for Pig Sales Market Share by Country in 2026
Figure 55. Europe Live Attenuated Vaccine for Pig Revenue Market Share by Country (2021-2026)
Figure 56. Europe Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 57. Europe Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 58. Germany Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 59. France Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Live Attenuated Vaccine for Pig Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Live Attenuated Vaccine for Pig Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Live Attenuated Vaccine for Pig Sales Market Share by Application (2021-2026)
Figure 66. Egypt Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Live Attenuated Vaccine for Pig Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Live Attenuated Vaccine for Pig in 2026
Figure 72. Manufacturing Process Analysis of Live Attenuated Vaccine for Pig
Figure 73. Industry Chain Structure of Live Attenuated Vaccine for Pig
Figure 74. Channels of Distribution
Figure 75. Global Live Attenuated Vaccine for Pig Sales Market Forecast by Region (2027-2032)
Figure 76. Global Live Attenuated Vaccine for Pig Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Live Attenuated Vaccine for Pig Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Live Attenuated Vaccine for Pig Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Live Attenuated Vaccine for Pig Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Live Attenuated Vaccine for Pig Revenue Market Share Forecast by Application (2027-2032)
